The RING family zinc-finger protein topors (topoisomerase I-binding protein) binds not only topoisomerase I, but also p53 and the AAV-2 Rep78/68 proteins. topors maps to human chromosome 9p21, which contains candidate tumor suppressor genes implicated in small cell lung cancers. In this study, we isolated the murine counterpart of topors and investigated its impact on p53 function. The deduced amino-acid sequence of mouse topors exhibits extensive similarity to human topors. Overexpressed myctagged topors associates with and stabilizes p53, and enhances the p53-dependent transcriptional activities of p21
Introduction
The p53 tumor suppressor protein is defined as the guardian of the genome, and more than half of all human cancers are characterized by either the loss of the p53 protein or by mutations in its gene (Lane, 1992; Ko and Prives, 1996) . The p53 protein comprises 393 amino acids including an amino-terminal transactivation domain, a sequence-specific DNA-binding domain and a multifunctional carboxyl-terminal domain. p53 is involved in the regulation of the cell cycle, apoptosis, senescence, DNA repair, cell differentiation and angiogenesis (Levine, 1997; Vogelstein et al., 2000) . These activities of p53 are mediated by one or more known mechanisms including the transcriptional regulation of target genes, functional regulation of interacting proteins, DNA annealing and exonuclease activity. p53 is activated by several stress conditions including DNA damage, the expression of several oncogene products, changes in cellular adhesion and redox potential, and reduction in the ribonucleoside triphosphate pool. In response to such stress signals, p53 undergoes extensive post-translational modification that modulates its stability and activity. The stabilization of p53 is presumed to play a major role in its activation, while modifications unrelated to p53 stabilization may regulate its specific activity (Sionov and Haupt, 1999; Vogelstein et al., 2000) . The stability of p53 is tightly regulated by multiple positive and negative feedback loops involving a number of p53 interacting proteins (Sionov and Haupt, 1999; Vogelstein et al., 2000) .
Human topoisomerase I-binding protein (h-topors) was first identified by yeast two-hybrid screening as a protein that interacts with human topoisomerase I (hTop1), and turned out to be identical to a novel p53-binding protein, p53BP3 (Haluska et al., 1999; Zhou et al., 1999 ). An identical protein was also isolated as the DNA-binding protein LUN, as a protein that interacts with adeno-associated virus type 2 (AAV-2) Rep78/68 proteins and as a protein binding to the interferon-inducible large GTPase Mx1 (Chu et al., 2001; Engelhardt et al., 2001; Weger et al., 2002) . h-topors is predicted to contain 1045 amino acids and to encode a RING family zinc-finger domain, a putative leucine zipper (LZ) domain, five sequences rich in proline, glutamine, serine and threonine (PEST sequences), an arginine/serine-rich (RS) domain and a bipartite nuclear localization signal (NLS). h-topors is modified by conjugation to the small ubiquitin-like modifier, SUMO-1 (Weger et al., 2003) , and both endogenous h-topors and overexpressed h-topors-GFP fusion protein are mainly distributed in promyelocytic leukemia-associated protein (PML) nuclear bodies in a PML protein-dependent fashion (Rasheed et al., 2002) . The carboxyl-terminal region of h-topors is required for such punctate nuclear localization (Rasheed et al., 2002) . In addition, the amino-terminal region of htopors, containing the RING zinc-finger motif and LZ region, has been shown to bind to DNA in a sequencespecific as well as Zn 2 þ -dependent manner (Chu et al., 2001) . Since h-topors enhances the expression of a Rep78/68-dependent AAV-2 gene in the absence of helper virus, h-topors might be a transcriptional regulator (Weger et al., 2002) .
Although h-topors interacts with p53 as revealed by yeast two-hybrid assay, the role of h-topors in regulating the function of p53 remains to be clarified (Zhou et al., 1999; Weger et al., 2002) . Several lines of evidence suggest that h-topors might be an important regulator in cell proliferation. Relocalization of topors in cells exposed to the Top1-targeting drug camptothecin (CPT) or the transcription inhibitor 5,6-dichloro-1-b-D-ribofuranolsylbenzimidazole (DRB) suggests its involvement in mediating the DNA damage response induced by CPT or DRB, which have been shown to cause an accumulation of p53 (Klibanov et al., 2001; Rasheed et al., 2002) . h-topors interacts with AAV-2 Rep78, which has been proved to be an effective repressor of the adenovirus in the process of tumor generation (Schlehofer, 1994) . Intriguingly, the region of h-topors required for interaction with AAV-2 Rep78/68 overlaps with that for p53 binding, as revealed by yeast two-hybrid analysis (Batchu et al., 1999; Weger et al., 2002) . In addition, h-topors maps to chromosome 9p21, a locus containing candidate tumor suppressor gene(s) associated with the loss of heterozygosity in 86% of small cell lung cancers (Chu et al., 2001) . These observations prompted us to examine the functional role of topors in the regulation of p53. In the present study, we describe a physical and functional interaction between mouse topors and p53 in mammalian cultured cells. Our results strongly suggest that topors acts as a coactivator of p53 in response to DNA damage.
Results

Identification of a murine counterpart of topors
To identify proteins that interact with the Polycomb group (PcG) protein Mph2 (Yamaki et al., 2002) , we employed yeast-based two-hybrid screening using a cDNA library derived from mouse embryo and bait derived from full-length Mph2. We isolated two identical 1.2-kb cDNA fragments encoding a polypeptide highly homologous to the carboxyl-terminal half of h-topors. By conventional cDNA screening of a mouse brain cDNA library and database screening, two overlapping clones, a 3.5-kb fragment lacking the aminoterminal region and a mouse EST clone lacking the carboxyl-terminal region, were isolated. The nucleotide sequences of both clones were determined, and the combined nucleotide sequences revealed the longest open reading frame (ORF) of 1033 amino-acid residues with 86% overall identity to h-topors (DDBJ accession number: AB104865). In the amino-terminal region, a RING family zinc-finger domain and an LZ region exhibited 100 and 98% homology to h-topors, respectively (red letters and open blue box in Figure 1a , respectively). The p53-binding domains of h-topors were previously shown to be separated into two blocks based on yeast two-hybrid interactions (underlined in Figure 1a ) (Zhou et al., 1999; Weger et al., 2002) . A bipartite NLS was present in the amino-terminal block of the p53-binding domains (blue letters in Figure 1a) . A cluster of residues including the two p53-binding subdomains and an intermediate region exhibited 90% identity with h-topors ( Figure 1b) . Because of the extensive similarity to h-topors, this newly isolated cDNA was identified as a murine counterpart of the htopors gene. The mouse topors gene was mapped to a 40 Mb region of mouse chromosome 4 by BLAST analysis of the mouse genome (40017898-40007704 bp; Ensemble Mouse Genome Browser), a region syntenic to human chromosome 9p21. This chromosomal localization is in agreement with a previous report in which human topors was mapped to the chromosome 9p21 region (Chu et al., 2001) .
h-topors has been shown to associate with PML nuclear bodies in exponentially growing HeLa cells (Rasheed et al., 2002) . To examine the subcellular localization of mouse topors in mammalian cultured cells, we constructed an expression vector encoding mycepitope-tagged topors (myc-topors) and confirmed its expression by in vitro transcription/translation experiments as well as transient transfection into COS-7 cells (Figure 1c and d) . Consistent with the previous observation, myc-topors migrated more slowly (195 kDa) than predicted based on the calculated molecular mass, which has been suggested to be due to the phosphorylation of serine residues in the RS domain (Haluska et al., 1999) . The subcellular localization of myc-topors was also examined in U2-OS cells by transient overexpression. In interphase nuclei of morphologically intact transfectants, the myc-topors protein was always localized in the nuclei. Two types of transfectants were reproducibly observed. One type exhibited a fine speckled distribution to form 10-20 foci and the other type showed larger, closely spaced dots with much stronger fluorescence in the nucleoplasm but excluded from the nucleolus (data not shown). These findings were identical to those of Haluska et al. (1999) , who described the subcellular localization of a GFP fusion with h-topors in HeLa cells.
topors interacts with p53 and enhances p53-dependent transcription in mammalian cultured cells
The putative p53-binding domains revealed by yeast two-hybrid interaction (Zhou et al., 1999; Weger et al., 2002) are highly conserved between human and mouse topors (Figure 1a and b) . This prompted us to examine whether myc-topors could interact with p53 in mammalian cultured cells. COS-7 cells were transiently transfected with myc-topors, and whole-cell extracts of the transfectants were subjected to immunoprecipitation with anti-p53 or normal mouse serum (NMS). As shown in Figure 2a , the anti-p53, but not the NMS, immunoprecipitates contained significant amounts of myc-topors, indicating that overexpressed myc-topors could associate with endogenous p53. This finding is consistent with the previous yeast two-hybrid studies demonstrating topors-p53 interaction (Zhou et al., 1999; Weger et al., 2002) . We next addressed whether the physical interaction of topors with p53 might affect the function of p53. To this end, we examined the effects of overexpressed myc-topors on the p53-dependent transcription of Bax, p21
Waf1 and MDM2 promoters using luciferase assays in transiently transfected p53-deficient SAOS-2 and H1299 cells (Barak et al., 1993; elDeiry et al., 1993; Miyashita and Reed, 1995) . As shown in Figure 2b , the overexpression of myc-topors in SAOS-2 cells significantly enhanced p53-dependent transcription of the Bax and MDM2 promoters in a dose-dependent manner. While myc-topors enhanced the p53-dependent activity of the p21 Waf1 promoter in SAOS-2 cells, this effect did not achieve statistical significance (Figure 2b , middle panel). Similar results were obtained in H1299 cells, except that its effect on all three p53-responsive promoters was statistically significant as compared with p53 alone (Figure 2c ). Under our experimental conditions, myc-topors alone had no effects on the Bax, p21
Waf1 or MDM2 promoter activity. We further studied whether the overexpression of topors influenced the expression of endogenous p53-regulated transcripts by quantitative real-time RT-PCR analysis of human p21 Waf1 mRNA levels. As shown in Figure 2d and e, forced expression of topors enhanced the transcription of the p53 downstream gene p21
Waf1 in both human small cell lung cancer SBC3 cells and U2-OS cells. Taken together, the results indicate that overexpression of topors enhances the sequence-specific transcriptional activity of p53 in a p53-dependent manner. These observations prompted us to investigate further whether the overexpression of myc-topors influences the growth suppression mediated by p53. For this purpose, we performed a colony formation assay using H1299 cells (lacking endogenous p53) and U2-OS cells containing the wild-type p53 allele. The overexpression of myctopors did not affect colony number in H1299 cells, while the colony number was significantly reduced in a dose-dependent manner in U2-OS cells (Figure 3a and b). The forced expression of p53 significantly reduced the colony number in H1299 cells, and this p53-dependent reduction was further intensified by cotransfection of pcDNA3-myc-topors ( Figure 3a) . Thus, the overexpression of topors appears to enhance the p53-dependent growth suppression of tumor cells.
In different systems, p53 can induce apoptosis or cause cell cycle arrest Vogelstein et al., 2000) . Because topors was able to enhance p53-dependent growth suppression, we next examined whether topors-dependent growth suppression involves apoptosis. The number of apoptotic cells exhibiting nuclear condensation and fragmentation was counted 48 h after transfection with either pcDNA3-myc-topors or pEGFP (Figure 3c -I-III). The number of apoptotic cells increased significantly among U2-OS cells overexpressing myc-topors compared to pEGFP transfectants (Figure 3c-IV) . Thus, the growth suppression resulting from overexpression of topors may result in part from induction of apoptosis.
Since p53 activation is known to cause not only apoptosis but also cell cycle arrest, we next examined the impact of overexpressed myc-topors on cell cycle progression. For this purpose, we established stable cell lines overexpressing myc-topors. U2-OS cells were transfected with pcDNA3-myc-topors, and G418-resistant clones were individually isolated and screened for myc-topors expression by immunofluorescent staining. Two cell lines out of 200 clones screened were found to express myc-topors (topors sta-1 and topors sta-2), and topors sta-1 expressed myc-topors at a higher level than topors sta-2 ( Figure 4a ). In both of the stable transfectants, myc-topors exhibited a speckled nuclear distribution to form 10-20 foci (Figure 4b ), as did endogenous mouse topors in NIH 3T3 fibroblasts (data not shown) and as reported for endogenous human topors (Rasheed et al., 2002) . topors sta-1 and topors sta-2 cells displayed a significantly slower growth rate Waf1 is upregulated by overexpression of myc-topors in small cell lung cancer cell SBC3 (d) and U2-OS cells (e). The expression of human p21
Waf1 was determined by quantitative real-time RT-PCR analysis as described in Materials and methods. Relative expression levels of p21
Waf1 were normalized to the levels of b-actin mRNA. The data shown are representative of two independent experiments with similar results. The significance of the differences was evaluated by Student's t-test (*Po0.05) topors is a coactivator of p53 L Lin et al compared with the parental U2-OS cells and U2-OS cells transfected with empty vector (V-1) (Figure 4c ). Of note, topors sta-1 cells grew more slowly than topors sta-2 cells, suggesting that the growth rate correlated inversely with the level of myc-topors expression in the respective cell lines. Next, asynchronous cultures of these transfectants and the parental cells were collected at 48 h after culture and their cell cycle distribution was analysed by flow cytometry. As shown in Figure 4d (cisplatin (À)) and e, topors sta-1 and topors sta-2 cells displayed a significant increase in the percentage of cells in G1 phase as compared with U2-OS and V-1 cells. A slight but reproducible increase in the sub-G1 fraction was seen exclusively in topors sta-1 cells (even without cisplatin treatment; see below), suggesting the constitutive occurrence of apoptosis in the topors sta-1 transfectants ( Figure 4d and f (cisplatin (À))). The severe growth retardation of U2-OS cells stably expressing myc-topors might therefore result from both a prolonged G1 phase and a subtle induction of apoptosis. Comparison of the topors sta-1 and topors sta-2 results suggests that overexpression of topors can result in growth arrest and/or apoptosis depending on the degree of topors expression and the particular cellular context.
Stabilization of p53 by overexpression of topors
To determine whether the growth retardation produced by the stable overexpression of myc-topors was linked to the activation of p53, we next examined the expression of p53 and its response gene product, p21 Waf1 (Harper et al., 1993) , in permanent transfectants. p53 was more abundantly expressed in both topors sta-1 and topors sta-2 stable transfectants than in control cell lines and the expression of p21
Waf1 was greater in both topors Waf1 mRNA in small cell lung cancer cells and U2-OS cells shown above (Figure 2d and e) . Importantly, the upregulation of p53 and p21
Waf1 proteins in topors sta-1 was stronger than in topors sta-2, consistent with the relative expression level of ectopic myc-topors and the severity of the growth phenotypes in the two cell lines. The levels of expression of the p53 protein could also be increased by transient overexpression of myc-topors in U2-OS cells and p53-deficient large cell lung carcinoma H1299 cells, which were cotransfected with both FLAG-tagged p53 and myc-topors (Figure 5c and d) . Since the level of p53 transcript was not significantly different in either of the permanent transfectants compared to controls (Figure 5b) , it is likely that the increase in the amount of p53 protein was due to its stabilization. To investigate whether an increased protein half-life contributed to the elevated levels of p53 observed, we then determined the decay rate of p53 protein without and with topors overexpression. At 24 h after culture of the empty vector stable cells (V-1) and topors sta-2 cells, or 24 h posttransient transfection of p53-deficient human large cell lung carcinoma H1299 cells with FLAG-p53 along with either pcDNA3 or pcDNA3-myc-topors, cells were treated with the protein synthesis inhibitor cycloheximide at a final concentration of 100 mg/ml for 0, 2, 4 and 6 h. The expression of p53 was then examined by immunoblotting for each time point and normalized by reference to the level of actin in each sample. As shown in Figure 5e , the p53 protein possessed a greater half-life in topors sta-2 cells compared with V-1 vector-transfected U2-OS cells. Similarly, the half-life of p53 was prolonged in the presence of topors compared to that of p53 cotransfected with pcDNA3 vector in p53-deficient topors is a coactivator of p53 L Lin et al H1299 cells (Figure 5f ). Taken together, these data suggest that expression of topors increases p53 levels by stabilizing p53 protein and thereby enhancing its ability to limit cell growth.
topors expression is induced by DNA damage Our finding that transient or stable transfection of topors upregulates p53 levels suggests that topors could be a rate-limiting factor in the regulation of p53 function. If this is the case, a quantitative alteration of topors expression in a given cell could affect its apoptotic response to genotoxic reagents. To address this possibility, exponentially growing U2-OS cells or stable transfectants were treated with 20 mM cisplatin for 24 h, and the cells were then subjected to the cell cycle analysis. Following cisplatin treatment, both topors sta-1 and topors sta-2 cells demonstrated significantly increased sub-G1 fractions compared to the control cells (Figure 4d and f) . The fraction of apoptotic cells among the topors sta-1 and topors sta-2 transfectants reached 80-90% after 48 h of cisplatin At 24 h after culture of pcDNA3 stable cells (V-1) and topors sta-2 cells (e), or at 24 h after transient transfection of p53-deficient H1299 cells (f) with expression plasmid of FLAG-p53 along with pcDNA3 or pcDNA3-myc-topors, cycloheximide was added to the culture medium and the cells were extracted at the indicated time points. Whole-cell lysates were subjected to immunoblotting. The relative intensities of p53 were quantified by densitometric scanning, which normalized to actin, and are represented graphically topors is a coactivator of p53 L Lin et al treatment, compared to only 30-40% in control cells (data not shown). Thus, the overexpression of topors enhances the apoptotic response of U2-OS cells to DNA damage.
This finding suggests that upregulation of endogenous topors might be involved in mediating p53-dependent cellular responses to stress stimuli. We thus examined the expression of endogenous topors after cisplatin treatment in U2-OS cells. topors expression was obviously upregulated 24 and 48 h after cisplatin treatment consistent with the expression of p53 protein (Figure 6a ). The analysis was extended to primary MEFs and C-20 cells, a mouse cell line derived from colon carcinoma. In these cells before treatment, topors was constitutively expressed while p53 was barely detectable. The apoptotic response of MEFs and C-20 cells to 20 mM cisplatin was more prominent than that of U2-OS cells (Figure 6b and c; compare to Figure 4d ). The expression of the topors gene and p53 protein was increased in MEFs and C-20 cells by cisplatin treatment as well (Figure 6b and c) . Since topors is a topoisomerase I-binding protein, we further investigated whether the expression of topors is also induced after treatment by CPT, a potent antineoplastic inhibitor of topoisomerase I (Haluska et al., 1999) . As shown in Figure 6d , when U2-OS cells and NIH 3T3 cells were treated with CPT at the concentration of 10 mM, the expression of topors increased more than twofold compared to cells without treatment. However, it is still possible that the upregulation of topors mRNA might be a consequence of p53 induced during DNA damage-induced apoptosis. To exclude this possibility, we examined topors expression after overexpression of p53 by transient transfection. The overexpression of p53 did not significantly affect topors transcript levels (Figure 6e ). Taken together, the induction of topors by the genotoxic reagents provides a mechanism to facilitate the p53-mediated DNA damage-dependent apoptosis in tumor and primary cells. 
Discussion
In the present study, we identify the mouse counterpart of human topors and document its involvement in p53-regulated cell growth control. Overexpressed topors associates with p53, activates p53-dependent transcription via the stabilization of p53 and, consequently, induces either cell cycle arrest or apoptosis in a dosedependent manner. Therefore, our observations strongly implicate the topors protein as a novel coactivator of the p53 tumor suppressor protein.
We further show that expression of endogenous topors, as well as the p53 protein, is induced by DNA damage in tumor and primary cells. The present observations indicate that topors mediates p53-dependent cellular responses to some forms of DNA damage and, thus, could act as a tumor suppressor that activates p53. Interestingly, the human topors gene maps to chromosome 9p21 where the tumor suppressor genes associated with 86% of small cell lung carcinomas are suggested to reside and the above observations provide further evidence for the topors gene as a candidate tumor suppressor gene mapped to this region. Our preliminary studies have revealed that topors mRNA is expressed in all small cell lung cancer cell lines at levels similar to other tumor cell lines (L Lin and A Hata, unpublished data). Most recently, Oyanagi et al. (2004) revealed that the expression of LUN (topors) gene is downregulated in the development and metastases of lung cancer, suggesting that LUN might play important roles in inhibiting the oncogenesis of non-small cell lung cancer. The expression of topors protein in normal lung tissues and small cell lung cancers will require further future study.
The data clearly show that the overexpression of topors may cause either cell cycle arrest or apoptosis, and suggest that which occurs depends both on the topors level and the cellular context, although other variables require further exploration. There is a positive correlation between the amount of p53 protein and overexpressed topors in U2-OS cells in both transient and stable transfectants. Since it has repeatedly been reported that low levels of p53 expression are antiapoptotic while high levels promote apoptosis, high levels of topors could facilitate apoptosis due to the high level of p53 expression (Chen et al., 1996; Lassus et al., 1996) . This phenomenon is further supported by another observation made in this study. We identified only two stable transfectants overexpressing myc-topors from 200 G418-resistant colonies and both exhibited a lower level of topors expression than that seen in the transiently transfected cells. This implies that only U2-OS cells overexpressing permissive amounts of exogenous topors might be allowed to survive by escaping apoptotic outbursts and instead exhibiting G1 cell cycle arrest, which is correlated with the induction of the downstream gene of p53, p21
Waf1 . Interestingly, slight but significant apoptotic outbursts coincide with G1 arrest in topors sta-1, but not sta-2, cells. Slightly higher expression levels of myc-topors and, consequently, p53 in topors sta-1 cells than in sta-2 cells may be the cause for this phenotypical difference.
Our findings demonstrate that the expression level of topors protein may be a rate-limiting factor in the regulation of p53 activity. While this manuscript was in preparation, Saleem et al. (2004) also reported that transient expression of h-topors showed antiproliferative activity and was associated with G0/G1 cell cycle arrest in HeLa cells. Our results additionally show that overexpression of topors could activate the expression of p53 and induce either cell cycle arrest or apoptotic response.
In this study, we show that endogenous topors is significantly upregulated by the genotoxic reagents at the level of transcription in tumor and primary cells. A previous study has suggested that post-translational regulation of topors by DNA damage may also be involved (Rasheed et al., 2002) . In that study, overexpressed GFP-topors fusion protein immediately relocalized from PML nuclear bodies to the nucleoplasm in cells exposed to CPT or DRB. Since DRB exposure has also been shown to induce the accumulation of diffuse p53 in the nucleoplasm, it is possible that the relocalization of topors into the nucleoplasm might allow its association with and subsequent stabilization of p53 (Klibanov et al., 2001) .
The stability of the tumor suppressor p53 is crucial for its function to induce cell cycle arrest and/or apoptosis as a consequence of its ability to bind to specific DNA sequences and activate the transcription of adjacent genes (Vogelstein et al., 2000) . Overexpression of topors increased the stability of p53 and correspondingly enhanced the p53-dependent transcriptional activities. topors contains a RING finger motif, a domain that has been implicated in protein-DNA and protein-protein interactions, E2-dependent ubiquitination and SUMO conjugation (Kahyo et al., 2001; Matthews and Sunde, 2002) . Indeed, topors proteins have been recently shown to possess evolutionarily conserved E3 ubiquitin ligase activity. A Drosophila topors was shown to mediate Hairy polyubiquitination, resulting in Hairy, but not Dmp53 or topoisomerase I (dTopoI), degradation (Secombe and Parkhurst, 2004) . Human GFP-topors fusion protein was shown to function as an E3 ligase for p53, albeit to a lesser degree than MDM2 . Therefore, topors could affect the stability of p53 via covalent modification of p53 by ubiquitin isopeptide. This observation, however, is not necessarily consistent with our and others' previous observations suggesting topors as a likely tumor suppressor protein since polyubiquitination of p53 mediated by GFPtopors induces proteasome-dependent downregulation of p53 in U2-OS cells (Chu et al., 2001; Rajendra et al., 2004; Saleem et al., 2004) . This implies that regulation of p53 by topors may involve not only ubiquitination but also some other molecular mechanism.
Recently, the activity of p53 has been reported to be positively regulated by SUMO conjugation, which is mediated, at least in part, by another RING finger protein, PIAS (Gostissa et al., 1999; Rodriguez et al., 1999; Kahyo et al., 2001) . Sequence similarity between topors is a coactivator of p53 L Lin et al two regions of topors and human PIASx protein, the RING domains and putative SUMO-1 interaction motifs suggests the possibility that topors may function as a SUMO E3 ligase (Weger et al., 2003) . Indeed, htopors and several components of SUMO-conjugating systems have been isolated together as interacting proteins with Mx1, an interferon-inducible GTPase that is associated with PML nuclear bodies (Engelhardt et al., 2001) , which include p53, pRb, DAXX and CBP (Mann and Miller, 2004) . Thus, topors may contribute to p53 stabilization or activation via SUMO conjugation processes.
The molecular mechanisms underlying the stabilization and/or activation of p53 by topors may also involve protein-protein interactions. AAV-2 Rep78/68 has been shown to possess a tumor suppressor property and to bind physically to p53 to prevent the adenovirusmediated degradation of p53 (Batchu et al., 1999) . Since topors is capable of interacting not only with p53, but also with Rep78/68, topors may cooperate with Rep78/ 68 to stabilize p53. It is possible that endogenous cellular regulators of p53 may function in ways analogous to these viral products and cooperate with topors to stabilize p53. These possibilities are not necessarily mutually exclusive. It will be essential to address experimentally the possible catalytic activities of topors.
Materials and methods
Isolation and preparation of an expression vector for a fulllength cDNA of topors Yeast two-hybrid screening was performed to isolate the cDNAs for Mph2-binding proteins from a cDNA library derived from E11.0 mouse embryo as described previously, and 177 independent clones were found to be positive for bgalactosidase activities as examined by filter assay (Vojtek et al., 1993; Kingma and Osheroff, 1998; Yamaki et al., 2002) . The nucleotide sequences of the positive cDNA clones were determined. Two clones contained 1.2-kb cDNA fragments that were highly homologous to h-topors (Haluska et al., 1999) . To isolate a full-length topors cDNA, a radiolabeled 1.2-kb cDNA fragment was used as a probe to screen the mouse brain cDNA library. After three rounds of hybridization, six positive clones were obtained and their nucleotide sequences were determined. The longest cDNA, containing a 3.5-kb insert, turned out to encode from the RING finger motif to the stop codon, but lacked a putative topors initiation codon. By searching public databases of mouse ESTs, we found a cDNA clone (MNCb-6014) that overlapped with the 3.5-kb cDNA clone. MNCb-6014, which was kindly provided by Dr Katsuyuki Hashimoto (Division of Genetic Resources, National Institute of Infectious Diseases, Japan), contained a topors initiation codon, but instead lacked the carboxylterminal region. To generate an expression vector encoding a full-length topors, the 5 0 -region of MNCb-6014 was amplified with primers 5 0 -CGTCGACAAGCTTATGGGGTCGCAGC CGCC-3 0 (the SalI/HindIII restriction sites are underlined) and 5 0 -CAGAAGACAGTTCAACAAGTTCCGGGGTCC-3 0 using the MNCb-6014 cDNA clone as a template. The PCR product was digested with SalI and SphI and subcloned into the identical restriction sites of the above-mentioned plasmid containing the 3.5-kb insert to produce a full-length cDNA for topors (pBluscript-M-topors). The pBluscript-M-topors was digested with HindIII and NotI and introduced into the identical restriction sites of pcDNA3-myc (Invitrogen, Carlsbad, CA, USA) to generate an expression vector for myctagged topors (pcDNA3-myc-topors).
In vitro transcription/translation of the topors gene product
The topors protein was generated from the pcDNA3-myctopors vector using the T7-TNT Quick-Coupled Transcription-Translation system (Promega, Madison, WI, USA) in the presence of [ 35 S]methionine (Amersham Biosciences Inc., Piscataway, NJ, USA) according to the manufacturer's instructions. The quality of the synthesized protein was verified by electrophoresis though an 8% SDS-polyacrylamide gel and autoradiography.
Cell culture and transfection
Human osteosarcoma cell lines U2-OS and SAOS-2, COS-7, NIH/3T3 and primary MEFs were maintained in DMEM supplemented with 10% FBS and antibiotics. Human large cell lung carcinoma H1299 cells and human small cell lung cancer SBC3 cells were grown in RPMI-1640 medium supplemented with 10% FBS and antibiotics. All cells were cultured at 371C in a water-saturated atmosphere of 5% CO 2 in air. COS-7 and U2-OS cells contain wild-type p53, while SAOS-2 and H1299 cells are deficient in p53 expression. For transfection, U2-OS cells were transfected by either the calcium phosphate coprecipitation method or Lipofectamine 2000 transfection reagent (Invitrogen, Grand Island, NY, USA) in accordance with the manufacturer's specifications. COS-7 cells were transfected with the FuGENE6 transfection reagent (Roche Molecular Biochemicals, Indianapolis, IN, USA). H1299 and SAOS-2 cells were transfected with the LipofectAMINE Plus transfection kit (Invitrogen, Grand Island, NY, USA) according to the manufacturer's protocol. To obtain stable transfectants, either pcDNA3 or pcDNA3-myc-topors was introduced into the exponentially growing U2-OS cells by the calcium phosphate co-precipitation method. At 48 h post-transfection, the cells were transferred to fresh medium containing G418 at a final concentration of 800 mg/ml. At 1 week after selection, drug-resistant colonies were isolated and the expression of myc-topors was examined by immunofluorescence staining as described below. As a control, a stable cell line of the pcDNA3 vector was established.
Immunoprecipitation and immunoblotting
Transfected cells were washed in ice-cold phosphate-buffered saline (PBS), lysed in lysis buffer (25 mM Tris-Cl, pH 7.5, 137 mM NaCl, 2.7 mM KCl, 1% Triton X-100 and 1 mM PMSF) and the extracts were sonicated briefly and centrifuged at 800 g for 5 min to remove insoluble materials. The protein concentrations were determined by the Bradford protein assay (Bio-Rad, Hercules, CA, USA) using BSA as a standard. For immunoprecipitation, the cell lysates prepared from COS-7 cells transfected with pcDNA3-myc-topors were precleared using protein G-Sepharose beads at 41C for 30 min under gentle rotation, and then incubated with either NMS or antibodies against p53 (DO-1, Oncogene Research Products, Cambridge, MA, USA and Pab1801, Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) at 41C for 2 h. The immune complexes were then recovered with protein G-Sepharose beads. The immunoprecipitates or supernatants were subjected to SDS-polyacrylamide gel electrophoresis and electrophoretically transferred onto Immobilon P membranes (Millipore 
Immunofluorescence and confocal microscopy
Transfected cells grown on coverslips were fixed with 3.7% formaldehyde for 30 min at room temperature, permeabilized with 0.2% Triton X-100 for 5 min at room temperature and then incubated with 3% BSA in PBS for 2 h to reduce nonspecific antibody binding. Immunostaining was performed by incubating cells with a monoclonal anti-myc antibody (9E10, diluted 1 : 10) for 1 h at room temperature in a humidified chamber, followed by incubation with fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse IgG (diluted 1 : 250) for 1 h at room temperature. The coverslips were washed extensively with PBS, mounted with PermaFluor (Immunon, Pittsburgh, PA, USA) and the labeled cells were examined using a confocal laser scan microscope (LSM510; Carl Zeiss Co., Ltd, Jena, Germany).
Luciferase reporter assay
SAOS-2 or H1299 cells were seeded at a density of 5 Â 10 4 cells/ well in a 12-well tissue culture dish and then cotransfected with 100 ng of p53/p73-responsive luciferase reporter constructs carrying Bax, p21
Waf1 or MDM2 promoter, 10 ng of pRL-TK and 25 ng of the p53 expression plasmid in either the presence or absence of increasing amounts of pcDNA3-myc-topors as described previously (Watanabe et al., 2002) . The total amounts of DNA used in each transfection were kept constant (510 ng/transfection) using pcDNA3. Luciferase assays were performed 48 h post-transfection with a dual luciferase reporter assay system (Promega) according to the manufacturer's instructions.
Quantitative real-time RT-PCR analysis
Small cell lung cancer cell SBC3 and U2-OS cells were transfected with pcDNA3 or myc-topors. At 48 h after transfection, total RNA was extracted with the RNeasy Mini kit (Qiagen Inc., Valencia, CA, USA). Quantitative real-time RT-PCR was performed using the Brilliant SYBR Green QRT-PCR Master Mix Kit, 1-Step (Stratagene, La Jolla, CA, USA) and specific primers for human p21
Waf1 and human bactin. Quantitative results of p21 Waf1 mRNA were normalized for the levels of b-actin mRNA. Specific primers for p21
Waf1 are as follows: 5 0 -ATGAAATTCACCCCCTTTCC-3 0 (forward primer) and 5 0 -CCCTAGGCTGTGCTCACTTC-3 0 (reverse primer).
Colony formation assay
U2-OS and H1299 cells were transfected with pcDNA3 or pcDNA3-myc-topors in the presence or absence of FLAG-p53 (a kind gift from Dr Toshiharu Suzuki, University of Tokyo, Tokyo, Japan). After 48 h of culture, the cells were divided into new dishes and cultured for 2 weeks in the presence of 400 mg/ ml of G418. The cell dishes were fixed, stained with Giemsa's solution (Merck KgaA, 54271, Darmstadt, Germany, Art. 1.09204) and the colonies were counted.
Analyses of cell cycle and apoptosis
After treating cells with or without cisplatin (Sigma Chemical Co., St Louis, MO, USA) at a final concentration of 20 mM for 24 h, both floating and adherent cells were collected by brief centrifugation, fixed in 70% (v/v) ethanol for more than 4 h at À201C and stained with PI (Sigma Chemical Co., St Louis, MO, USA). To identify cells with sub-G1 DNA content, the fluorescence of the nuclei was measured by flow cytometry (FACScan, Becton Dickinson, Oxford, UK). At least 5 Â 10 4 events were analysed with Cell Quest software. For the morphological assessment of fragmented nuclei, U2-OS cells grown on coverslips were transfected with either myc-topors or pEGFP-N3 (BD Biosciences, CA, USA). At 48 h posttransfection, the cells were fixed with 3.7% formaldehyde, permeabilized with 0.2% Triton X-100 and blocked with 3% BSA in PBS. myc-topors was visualized with 9E10 monoclonal antibody (diluted 1 : 10) followed by FITC-conjugated goat anti-mouse IgG (diluted 1 : 250). DNA was visualized by incubating the cells with 1 mM Hoechst 33258 dye. Cells showing apoptotic morphological changes were analysed under a Leica QFluoro confocal spectral microscope (Leica Microsystems Imaging Solutions Ltd, Cambridge, UK).
Protein half-life determination
At 24 h after culture of the pcDNA3 stable cells (V-1) and topors sta-2 cells, or at 24 h post-transfection of p53-deficient human H1299 cells with FLAG-p53 in combination with either pcDNA3 or pcDNA3-myc-topors, cycloheximide (Sigma) was added to the cell culture medium at a final concentration of 100 mg/ml. Cells were collected at the indicated time points and whole-cell extracts were subjected to immunoblot analysis with anti-p53 antibody. Best-fit linear regression analysis of the data points was performed with Prism 4.0 software (GraphPad).
Northern blot analysis
U2-OS cells, MEFs, C-20 cells and NIH/3T3 cells were cultured in the presence of cisplatin (20 mM) for 24 or 48 h or CPT (10 mM) for 12 h. Total cellular RNA was isolated using the Isogen kit (Wako Pure Chemical Industries, Ltd, Osaka, Japan). RNA (10 mg) was denatured in formaldehyde-formamide, separated by electrophoresis in 1.5% agarose gels and transferred to Hybond TM -N þ membranes (Amersham Biosciences, Tokyo, Japan). The resulting blots were individually hybridized with radiolabeled probes specific for topors and p53 at 651C for more than 10 h. The filters were washed twice with 2 Â SSC (300 mM NaCl and 30 mM sodium citrate, pH 7.0)/ 0.1% N-lauroyl sarcosine at room temperature for 30 min, and then once with 1 Â SSC/0.1% N-lauroyl sarcosine at 551C for 30 min.
Statistical analysis
Statistical analyses were performed using the unpaired Student's t-test. The differences between two groups were considered to be statistically significant when Po0.05.
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